Stock data

全福生技 (6885)

全福生技 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$1.23M, up 209.5% from a year earlier. EPS over the last four quarters totals -NT$3.26.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 全福生技 in Insightr